<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02213341</url>
  </required_header>
  <id_info>
    <org_study_id>DAIT CoFAR9</org_study_id>
    <nct_id>NCT02213341</nct_id>
  </id_info>
  <brief_title>Impact of Vaccination on Th2 Immunity in Infancy</brief_title>
  <official_title>Impact of Vaccination on Th2 Immunity in Infancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Consortium of Food Allergy Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute of Allergy and Infectious Diseases (NIAID)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the responses in the immune system of infants after&#xD;
      they receive the vaccine against diphtheria, tetanus, and pertussis (DTaP). The investigators&#xD;
      will do this by studying the immune cells and allergy responses in the blood prior to and&#xD;
      after receipt of the third DTaP vaccine.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-site study of infants who are scheduled to receive their third series (~6&#xD;
      month) vaccinations, as routine care, to investigate whether the diphtheria, tetanus, and&#xD;
      pertussis (DTaP) vaccination has an effect on specific immunoglobulin E (IgE) levels to milk,&#xD;
      egg, or peanut. Infants will be assigned to one of two groups depending on the infant's&#xD;
      sensitization to milk, egg, and peanut.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of enrollment.&#xD;
  </why_stopped>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">June 14, 2016</completion_date>
  <primary_completion_date type="Actual">June 14, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Allergen-specific IgE</measure>
    <time_frame>baseline and day 28</time_frame>
    <description>Magnitude of increase of allergen-specific IgE. For each child, the maximum allergen-specific IgE change to milk, egg, or peanut will be considered as the primary endpoint.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">77</enrollment>
  <condition>Food Hypersensitivity</condition>
  <arm_group>
    <arm_group_label>Positive blood test to milk, egg, and/or peanut</arm_group_label>
    <description>Family history to atopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Negative blood test to allergy</arm_group_label>
    <description>A negative skin prick test to egg, milk, and peanut and a negative Immunoglobulin E (IgE) to egg, milk, and peanut.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Skin prick allergen test</intervention_name>
    <description>To test for hypersensitivity to milk, egg, or peanut</description>
    <arm_group_label>Negative blood test to allergy</arm_group_label>
    <arm_group_label>Positive blood test to milk, egg, and/or peanut</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood draw</intervention_name>
    <arm_group_label>Negative blood test to allergy</arm_group_label>
    <arm_group_label>Positive blood test to milk, egg, and/or peanut</arm_group_label>
    <other_name>venipuncture</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Infants who are scheduled to receive their ~6 month (third dose of primary series) vaccines&#xD;
        including the DTaP vaccine as part of routine care.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent from parent/guardian&#xD;
&#xD;
          -  General good health without other known need for blood draws that would conflict with&#xD;
             the study volume requirements&#xD;
&#xD;
          -  Aged 5 months - 7 months, any race/ethnicity, any gender&#xD;
&#xD;
          -  Subjects must not have yet received their third DTaP vaccination, which typically is&#xD;
             given at 6 months of age. Subjects must have previously received two doses of the DTaP&#xD;
             vaccination, at ages 2 months and 4 months&#xD;
&#xD;
          -  Willingness to return for follow-up testing as defined in the protocol and consent if&#xD;
             screening tests indicate eligibility&#xD;
&#xD;
          -  Group 1 participants must have all of the following:&#xD;
&#xD;
               -  A negative skin prick test to egg, milk, and peanut&#xD;
&#xD;
               -  A negative IgE to egg, milk, and peanut&#xD;
&#xD;
          -  Group 2 participants must have all of the following:&#xD;
&#xD;
               -  A positive family history of allergic disease&#xD;
&#xD;
               -  Atopic Dermatitis not requiring prescription medication&#xD;
&#xD;
               -  A positive IgE to milk, egg, and/or peanut&#xD;
&#xD;
        If Group 1 enrollment is completed first, participants must have all of the following to be&#xD;
        enrolled in Group 2:&#xD;
&#xD;
          -  A family history of atopy&#xD;
&#xD;
          -  Atopic dermatitis not requiring prescription medication&#xD;
&#xD;
        If Group 2 enrollment is completed first, participants must have all of the following to be&#xD;
        enrolled in Group 1:&#xD;
&#xD;
        -No personal or family history of atopic disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of anemia requiring any treatment&#xD;
&#xD;
          -  Previous allergic reaction to any food, defined as itching, rash, hives, swelling,&#xD;
             vomiting, diarrhea, sneezing, rhinorrhea, wheezing, breathing difficulty, or passing&#xD;
             out immediately after food ingestion.&#xD;
&#xD;
          -  Evidence of non-IgE-mediated reaction to milk or soy (i.e. milk/soy protein&#xD;
             intolerance) or evidence of food protein induced enterocolitis syndrome (FPIES)&#xD;
&#xD;
          -  Severe atopic dermatitis (liberally defined as requiring prescription medication)&#xD;
&#xD;
          -  Unable to obtain serum sample for determination of egg, milk and peanut IgE levels&#xD;
&#xD;
          -  Use of short-acting anti-histamines (diphenhydramine, etc.) more than one time within&#xD;
             3 days of skin testing or on the day of skin testing&#xD;
&#xD;
          -  Any history of intravenous or oral steroid medication&#xD;
&#xD;
          -  Known underlying immune defect/deficiency or bleeding disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Months</minimum_age>
    <maximum_age>7 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hugh A. Sampson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mt. Sinai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Scott Sicherer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.niaid.nih.gov/</url>
    <description>National Institute of Allergy and Infectious Diseases (NIAID)</description>
  </link>
  <link>
    <url>https://www.niaid.nih.gov/about/dait</url>
    <description>Division of Allergy, Immunology, and Transplantation (DAIT)</description>
  </link>
  <link>
    <url>http://www.cofargroup.org/</url>
    <description>Consortium of Food Allergy Research (CoFAR)</description>
  </link>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>August 7, 2014</study_first_submitted>
  <study_first_submitted_qc>August 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2014</study_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Milk Allergy</keyword>
  <keyword>Egg Allergy</keyword>
  <keyword>Peanut Allergy</keyword>
  <keyword>Infant Vaccination</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Food Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

